BOUT vs. GERM ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to ETFMG Treatments Testing and Advancements ETF (GERM)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$33.60
Average Daily Volume
2,129
59
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.Grade (RS Rating)
Last Trade
$16.47
Average Daily Volume
1,945
48
Performance
| Period | BOUT | GERM |
|---|---|---|
| 30 Days | -7.11% | -8.64% |
| 60 Days | -3.52% | -9.90% |
| 90 Days | 1.80% | -11.43% |
| 12 Months | 12.27% | -20.09% |
0 Overlapping Holdings
| Symbol | Grade | Weight in BOUT | Weight in GERM | Overlap |
|---|
BOUT Overweight 59 Positions Relative to GERM
| Symbol | Grade | Weight | |
|---|---|---|---|
| FTI | A | 3.47% | |
| KSPI | A | 3.34% | |
| AZEK | D | 3.2% | |
| MSDL | A | 3.17% | |
| TBBB | D | 3.16% | |
| BLDR | C | 3.16% | |
| HEAR | B | 3.15% | |
| TXRH | A | 3.14% | |
| LEN | D | 3.13% | |
| WING | A | 3.09% | |
| HUBS | B | 2.97% | |
| GPS | D | 2.84% | |
| IBKR | A | 2.8% | |
| CELH | D | 2.8% | |
| XYL | A | 2.75% | |
| JPM | B | 2.73% | |
| SAP | C | 2.72% | |
| FROG | C | 2.7% | |
| DUOL | B | 2.7% | |
| PCOR | D | 2.63% | |
| APPF | C | 2.61% | |
| IOT | C | 2.48% | |
| GOOGL | A | 1.87% | |
| GOOG | A | 1.87% | |
| CRM | D | 1.85% | |
| PCAR | D | 1.82% | |
| RCL | A | 1.81% | |
| IRM | B | 1.81% | |
| SHAK | B | 1.8% | |
| FOR | D | 1.8% | |
| AXP | A | 1.8% | |
| ERJ | A | 1.77% | |
| CROX | C | 1.72% | |
| SEMR | D | 0.93% | |
| PWR | A | 0.93% | |
| NTAP | A | 0.93% | |
| GVA | A | 0.92% | |
| ERIE | D | 0.92% | |
| URI | B | 0.91% | |
| TOL | C | 0.89% | |
| ISRG | C | 0.89% | |
| RL | C | 0.85% | |
| KNSL | D | 0.78% | |
| ELF | C | 0.76% | |
| WAB | A | 0.35% | |
| SKWD | C | 0.35% | |
| PSTG | A | 0.35% | |
| NVDA | D | 0.35% | |
| ANET | C | 0.35% | |
| WMS | C | 0.34% | |
| PLTR | C | 0.34% | |
| KKR | C | 0.34% | |
| OKTA | D | 0.33% | |
| LRN | B | 0.33% | |
| FIHL | A | 0.33% | |
| DFH | D | 0.33% | |
| ASML | D | 0.33% | |
| TREX | C | 0.32% | |
| RYAN | D | 0.32% |
BOUT Underweight 48 Positions Relative to GERM
| Symbol | Grade | Weight | |
|---|---|---|---|
| MRNA | A | -7.5% | |
| DGX | A | -6.59% | |
| ALNY | F | -6.36% | |
| BNTX | F | -6.31% | |
| LH | F | -6.07% | |
| BIO | F | -3.93% | |
| DVAX | F | -3.79% | |
| PCVX | D | -3.71% | |
| IMCR | D | -3.35% | |
| ZLAB | F | -3.05% | |
| VIR | F | -2.97% | |
| OPK | C | -2.55% | |
| BCRX | F | -2.35% | |
| ARCT | F | -2.01% | |
| HLVX | F | -1.63% | |
| SIGA | A | -1.6% | |
| FLGT | F | -1.59% | |
| CVAC | F | -1.51% | |
| NVAX | F | -1.45% | |
| ABUS | B | -1.24% | |
| ADPT | F | -1.09% | |
| ALT | D | -1.06% | |
| OSUR | F | -0.99% | |
| RENB | F | -0.98% | |
| OCGN | C | -0.97% | |
| AZN | A | -0.95% | |
| LLY | D | -0.87% | |
| MRK | A | -0.87% | |
| PFE | F | -0.87% | |
| SNY | C | -0.86% | |
| GILD | F | -0.85% | |
| GSK | C | -0.85% | |
| ABBV | C | -0.83% | |
| ABT | D | -0.83% | |
| ENTA | F | -0.83% | |
| REGN | D | -0.83% | |
| JNJ | F | -0.81% | |
| TAK | F | -0.81% | |
| CRMD | B | -0.67% | |
| XBIT | B | -0.64% | |
| VXRT | F | -0.39% | |
| EBS | F | -0.26% | |
| IFRX | F | -0.21% | |
| CMRX | F | -0.21% | |
| CVM | F | -0.21% | |
| GRTS | F | -0.19% | |
| CUE | F | -0.18% | |
| VAXX | F | -0.14% |
BOUT: Top Represented Industries & Keywords
GERM: Top Represented Industries & Keywords
Compare ETFs
